Ayuvant
Harnessing the immune system to beat cancer
- Employees
- 1–10
- Business Model
- B2B
- Website
- ayuvant.com
About
Ayuvant is a preclinical-stage biopharmaceutical company developing a novel RNA-nanoparticle immunotherapy platform to treat cancer. The company's technology uses non-inflammatory RNA nanoparticles to instruct the immune system to recognize and attack cancer cells, offering an approach effective in patients who do not respond to current checkpoint inhibitors. Ayuvant's platform is designed for specific, durable immunotherapy that induces long-term immune memory and has demonstrated strong antitumor activity in checkpoint inhibitor-resistant models.
Summary
Ayuvant is a Biotech company.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ayuvant"><img src="https://indexed.vc/api/badge/company/ayuvant" alt="Ayuvant on Indexed.vc" width="260" height="76" /></a>